Literature DB >> 27123186

The Economic Value of Vaccination: Why Prevention is Wealth.

.   

Abstract

Entities:  

Keywords:  Vaccination; antibiotic resistance; benefits; budget; cancers; complications; cost-effectiveness; cost-saving; costs; economic analysis; economic evaluation; economic growth; healthcare resource use; healthcare system; indirect protection; intangible benefits; investment; macroeconomic; nosocomial infections; outbreaks; productivity; public health; quality of life; short-term; societal; vaccination; vaccine industry; vaccines complexity; value

Year:  2015        PMID： 27123186      PMCID： PMC4802700          DOI： 10.3402/jmahp.v3.29414

Source DB:  PubMed          Journal:  J Mark Access Health Policy        ISSN： 2001-6689


× No keyword cloud information.
  131 in total

1.  Economic evaluation of strategies for the control and management of influenza in Europe.

Authors:  P A Scuffham; P A West
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

Review 2.  A critical literature review of health economic evaluations in pertussis booster vaccination.

Authors:  Aurelie Millier; Samuel Aballea; Lieven Annemans; Mondher Toumi; Sibilia Quilici
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2012-02       Impact factor: 2.217

3.  Cost effectiveness of pertussis vaccination in adults.

Authors:  Grace M Lee; Trudy V Murphy; Susan Lett; Margaret M Cortese; Katrina Kretsinger; Stephanie Schauer; Tracy A Lieu
Journal:  Am J Prev Med       Date:  2007-03       Impact factor: 5.043

4.  Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine.

Authors:  Mélanie Drolet; Jean-François Laprise; Marie-Claude Boily; Eduardo L Franco; Marc Brisson
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

Review 5.  The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.

Authors:  Archana Chatterjee
Journal:  Expert Rev Vaccines       Date:  2014-09-26       Impact factor: 5.217

Review 6.  Valuing vaccination.

Authors:  Till Bärnighausen; David E Bloom; Elizabeth T Cafiero-Fonseca; Jennifer Carroll O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

Review 7.  Can HPV vaccine have other health benefits more than cancer prevention? A systematic review of association between cervical HPV infection and preterm birth.

Authors:  Qi-tao Huang; Mei Zhong; Yun-fei Gao; Li-ping Huang; Qiong Huang; Wei Wang; Zhi-jian Wang; Yan-hong Yu
Journal:  J Clin Virol       Date:  2014-09-16       Impact factor: 3.168

8.  Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.

Authors:  Hammad Ali; Basil Donovan; Handan Wand; Tim R H Read; David G Regan; Andrew E Grulich; Christopher K Fairley; Rebecca J Guy
Journal:  BMJ       Date:  2013-04-18

9.  The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK.

Authors:  E J Dasbach; R P Insinga; E H Elbasha
Journal:  BJOG       Date:  2008-05-22       Impact factor: 6.531

Review 10.  A systematic review of the cost effectiveness of herpes zoster vaccination.

Authors:  Thomas D Szucs; Alena M Pfeil
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.558
View more
  1 in total

1.  How Public Health Professionals View Mandatory Vaccination in Italy-A Cross-Sectional Survey.

Authors:  Erica Pitini; Valentina Baccolini; Annalisa Rosso; Azzurra Massimi; Corrado De Vito; Carolina Marzuillo; Paolo Villari
Journal:  Vaccines (Basel)       Date:  2021-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.